As 2026 begins, the global hepatology community is closely monitoring a wave of breakthrough data from Phase II and III trials that aim to permanently correct the ATP7B genetic mutation. Regulatory authorities in the European Union and the United States have recently signaled a willingness to accept biomarker-driven endpoints, such as long-term reduction in non-ceruloplasmin bound copper, to...

The US Allergic Rhinitis Market is segmented by type, treatment, and route of administration. Read more:👉 US Allergic Rhinitis Market Segmentation By type, seasonal allergic rhinitis holds the largest share, while perennial allergic rhinitis is growing rapidly. Occupational allergic rhinitis remains niche but important for specific industries. By treatment, antihistamines dominate due to...